Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterising the phenotype and mode of inheritance of patients with inherited peripheral neuropathies carrying MME mutations.
Lupo V, Frasquet M, Sánchez-Monteagudo A, Pelayo-Negro AL, García-Sobrino T, Sedano MJ, Pardo J, Misiego M, García-García J, Sobrido MJ, Martínez-Rubio MD, Chumillas MJ, Vílchez JJ, Vázquez-Costa JF, Espinós C, Sevilla T. Lupo V, et al. Among authors: misiego m. J Med Genet. 2018 Dec;55(12):814-823. doi: 10.1136/jmedgenet-2018-105650. Epub 2018 Nov 10. J Med Genet. 2018. PMID: 30415211
Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study.
Riancho J, Setien S, Sánchez de la Torre JR, Torres-Barquin M, Misiego M, Pérez JL, Castillo-Triviño T, Menéndez-García C, Delgado-Alvarado M. Riancho J, et al. Among authors: misiego m. Front Immunol. 2021 Mar 25;12:614715. doi: 10.3389/fimmu.2021.614715. eCollection 2021. Front Immunol. 2021. PMID: 33841397 Free PMC article.
Switch to ocrelizumab in MS patients treated with natalizumab in extended interval dosing at high risk of PML: A 96-week follow-up pilot study.
Santiago-Setien P, Barquín-Rego C, Hernández-Martínez P, Ezquerra-Marigomez M, Torres-Barquin M, Menéndez-Garcia C, Uriarte F, Jiménez-López Y, Misiego M, Sánchez de la Torre JR, Setien S, Delgado-Alvarado M, Riancho J. Santiago-Setien P, et al. Among authors: misiego m. Front Immunol. 2023 Feb 1;14:1086028. doi: 10.3389/fimmu.2023.1086028. eCollection 2023. Front Immunol. 2023. PMID: 36817456 Free PMC article.
Neuropathic pain and dysesthesia of the feet after Himalayan expeditions.
Ricart de Mesones A, Turón Sans J, Misiego M, Onaga Pueyo H, Real Soriano R, Botella de Maglia J. Ricart de Mesones A, et al. Among authors: misiego m. High Alt Med Biol. 2002 Winter;3(4):395-9. doi: 10.1089/15270290260512873. High Alt Med Biol. 2002. PMID: 12631425